Back to Search
Start Over
First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany.
- Source :
- Frontiers in Hematology; 2024, p1-7, 7p
- Publication Year :
- 2024
Details
- Language :
- English
- Database :
- Complementary Index
- Journal :
- Frontiers in Hematology
- Publication Type :
- Academic Journal
- Accession number :
- 178115815
- Full Text :
- https://doi.org/10.3389/frhem.2024.1335161